Swiss National Bank reduced its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 6.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,681,600 shares of the financial services provider’s stock after selling 112,500 shares during the quarter. Swiss National Bank owned approximately 0.24% of MetLife worth $137,689,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC increased its holdings in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the period. Peterson Financial Group Inc. acquired a new stake in shares of MetLife in the third quarter valued at about $30,000. Retirement Wealth Solutions LLC bought a new position in shares of MetLife during the fourth quarter worth about $32,000. Sierra Ocean LLC acquired a new position in shares of MetLife in the fourth quarter worth approximately $32,000. Finally, Coastline Trust Co bought a new stake in MetLife in the third quarter valued at approximately $35,000. Institutional investors own 94.99% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on MET. JPMorgan Chase & Co. upped their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Morgan Stanley upped their target price on MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a research report on Friday, February 28th. Keefe, Bruyette & Woods lowered their target price on MetLife from $100.00 to $98.00 and set an “outperform” rating for the company in a report on Wednesday, February 12th. TD Cowen increased their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Finally, Wells Fargo & Company lifted their price objective on shares of MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.
MetLife Trading Down 1.9 %
NYSE:MET opened at $77.69 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $67.30 and a one year high of $89.05. The company has a market cap of $52.92 billion, a PE ratio of 13.01, a PEG ratio of 0.65 and a beta of 1.04. The firm has a 50-day moving average of $83.48 and a 200-day moving average of $82.36.
MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities research analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.81%. The ex-dividend date was Tuesday, February 4th. MetLife’s dividend payout ratio is 36.52%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Why Are Stock Sectors Important to Successful Investing?
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is diluted earnings per share (Diluted EPS)?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Dividend Payout Ratio Calculator
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.